These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9207459)

  • 1. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma.
    Gascoyne RD; Adomat SA; Krajewski S; Krajewska M; Horsman DE; Tolcher AW; O'Reilly SE; Hoskins P; Coldman AJ; Reed JC; Connors JM
    Blood; 1997 Jul; 90(1):244-51. PubMed ID: 9207459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of Bax protein expression in diffuse aggressive non-Hodgkin's lymphoma.
    Gascoyne RD; Krajewska M; Krajewski S; Connors JM; Reed JC
    Blood; 1997 Oct; 90(8):3173-8. PubMed ID: 9376600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study.
    Hill ME; MacLennan KA; Cunningham DC; Vaughan Hudson B; Burke M; Clarke P; Di Stefano F; Anderson L; Vaughan Hudson G; Mason D; Selby P; Linch DC
    Blood; 1996 Aug; 88(3):1046-51. PubMed ID: 8704213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: an analysis of 83 cases.
    Tang SC; Visser L; Hepperle B; Hanson J; Poppema S
    J Clin Oncol; 1994 Jan; 12(1):149-54. PubMed ID: 8270971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between EBV DNA and rearrangement and expression of Bcl-2 gene in aggressive non-Hodgkin's lymphoma.
    Eissa S; Kassim SK; Imam M; Khalifa A
    IUBMB Life; 1999 Aug; 48(2):231-6. PubMed ID: 10794603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo nodal diffuse large B-cell lymphoma: identification of biologic prognostic factors.
    Abd El-Hameed A
    J Egypt Natl Canc Inst; 2005 Mar; 17(1):20-8. PubMed ID: 16353079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
    Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB
    Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma.
    Kramer MH; Hermans J; Wijburg E; Philippo K; Geelen E; van Krieken JH; de Jong D; Maartense E; Schuuring E; Kluin PM
    Blood; 1998 Nov; 92(9):3152-62. PubMed ID: 9787151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of bcl-2 (MBR)/JH rearrangement in the peripheral blood of patients with diffuse large B-cell lymphomas.
    Zucca E; Bertoni F; Bosshard G; Roggero E; Ceresa E; Sanna P; Pedrinis E; Cavalli F
    Ann Oncol; 1996 Dec; 7(10):1023-7. PubMed ID: 9037360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA).
    Hermine O; Haioun C; Lepage E; d'Agay MF; Briere J; Lavignac C; Fillet G; Salles G; Marolleau JP; Diebold J; Reyas F; Gaulard P
    Blood; 1996 Jan; 87(1):265-72. PubMed ID: 8547651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of bcl-2 gene rearrangement in B-cell Non-Hodgkin's lymphoma.
    Arif A; Jamal S; Mushtaq S; Ahmed S; Mubarik A
    Asian Pac J Cancer Prev; 2009; 10(2):237-40. PubMed ID: 19537891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2 rearrangements with breakpoints in both vcr and mbr in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.
    Merup M; Spasokoukotskaja T; Einhorn S; Smith CI; Gahrton G; Juliusson G
    Br J Haematol; 1996 Mar; 92(3):647-52. PubMed ID: 8616030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of t(14;18) and bcl-2 gene expression in follicular small cleaved cell lymphoma and diffuse large cell lymphoma.
    Martinka M; Comeau T; Foyle A; Anderson D; Greer W
    Clin Invest Med; 1997 Dec; 20(6):364-70. PubMed ID: 9413633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2 gene rearrangement in Jordanian follicular and diffuse large B-cell lymphomas.
    Almasri NM; Al-Alami J; Faza M
    Saudi Med J; 2005 Feb; 26(2):251-5. PubMed ID: 15770300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
    Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
    [No Abstract]   [Full Text] [Related]  

  • 16. MBR rearrangement and P-glycoprotein expression are not independent prognostic factors like p53 protein in malignant lymphoma.
    Sun RX; Coste J; Segara C; Rousset T; Fabbro M; Rème T; Legouffe E; Klein B; Rossi JF
    Clin Lab Haematol; 1998 Apr; 20(2):87-94. PubMed ID: 9681218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma.
    López-Guillermo A; Cabanillas F; McDonnell TI; McLaughlin P; Smith T; Pugh W; Hagemeister F; Rodríguez MA; Romaguera JE; Younes A; Sarris AH; Preti HA; Lee MS
    Blood; 1999 May; 93(9):3081-7. PubMed ID: 10216105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics and prognosis of concurrent positive t(14; 18) and myc gene rearrangement in diffuse large B cell lymphoma].
    Zhang HW; Chen ZW; Wang LY; He JX; Zheng YP; Han WE; Yang B; Wang YL; Zhao ZQ; Bai M; Su LP
    Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):206-10. PubMed ID: 26988827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients.
    Vitolo U; Gaidano G; Botto B; Volpe G; Audisio E; Bertini M; Calvi R; Freilone R; Novero D; Orsucci L; Pastore C; Capello D; Parvis G; Sacco C; Zagonel V; Carbone A; Mazza U; Palestro G; Saglio G; Resegotti L
    Ann Oncol; 1998 Jan; 9(1):55-61. PubMed ID: 9541684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone.
    Huebner-Chan D; Fernandes B; Yang G; Lim MS
    Mod Pathol; 2001 Oct; 14(10):1000-7. PubMed ID: 11598170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.